246 related articles for article (PubMed ID: 37049555)
21. Roux-en-Y gastric bypass surgery is effective in fibroblast growth factor-21 deficient mice.
Morrison CD; Hao Z; Mumphrey MB; Townsend RL; Münzberg H; Ye J; Berthoud HR
Mol Metab; 2016 Oct; 5(10):1006-1014. PubMed ID: 27689013
[TBL] [Abstract][Full Text] [Related]
22. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study.
De Bandt D; Rives-Lange C; Frigout Y; Bergerot D; Blanchard A; Le Gall M; Lacorte JM; Chevallier JM; Czernichow S; Poghosyan T; Carette C; Le Beyec J
Obes Surg; 2022 Mar; 32(3):757-762. PubMed ID: 34993850
[TBL] [Abstract][Full Text] [Related]
23. Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes.
Flynn CR; Albaugh VL; Tamboli RA; Gregory JM; Bosompem A; Sidani RM; Winnick JJ
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G370-G374. PubMed ID: 31709832
[TBL] [Abstract][Full Text] [Related]
24. Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss.
Plum L; Ahmed L; Febres G; Bessler M; Inabnet W; Kunreuther E; McMahon DJ; Korner J
Obesity (Silver Spring); 2011 Nov; 19(11):2149-57. PubMed ID: 21593800
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
26. Increased β-Cell Mass in Obese Rats after Gastric Bypass: A Potential Mechanism for Improving Glycemic Control.
Zhang S; Guo W; Wu J; Gong L; Li Q; Xiao X; Zhang J; Wang Z
Med Sci Monit; 2017 May; 23():2151-2158. PubMed ID: 28477035
[TBL] [Abstract][Full Text] [Related]
27. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats.
Chambers AP; Jessen L; Ryan KK; Sisley S; Wilson-Pérez HE; Stefater MA; Gaitonde SG; Sorrell JE; Toure M; Berger J; D'Alessio DA; Woods SC; Seeley RJ; Sandoval DA
Gastroenterology; 2011 Sep; 141(3):950-8. PubMed ID: 21699789
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.
Korner J; Inabnet W; Febres G; Conwell IM; McMahon DJ; Salas R; Taveras C; Schrope B; Bessler M
Int J Obes (Lond); 2009 Jul; 33(7):786-95. PubMed ID: 19417773
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats.
Sridhar A; Khan D; Abdelaal M; Elliott JA; Naughton V; Flatt PR; Le Roux CW; Docherty NG; Moffett CR
PLoS One; 2022; 17(9):e0274788. PubMed ID: 36137097
[TBL] [Abstract][Full Text] [Related]
30. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
Kashyap SR; Daud S; Kelly KR; Gastaldelli A; Win H; Brethauer S; Kirwan JP; Schauer PR
Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383
[TBL] [Abstract][Full Text] [Related]
31. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
Liu Y; Zhou Y; Wang Y; Geng D; Liu J
Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
[TBL] [Abstract][Full Text] [Related]
32. Calorie restriction and not glucagon-like peptide-1 explains the acute improvement in glucose control after gastric bypass in Type 2 diabetes.
Steven S; Hollingsworth KG; Small PK; Woodcock SA; Pucci A; Aribasala B; Al-Mrabeh A; Batterham RL; Taylor R
Diabet Med; 2016 Dec; 33(12):1723-1731. PubMed ID: 27589584
[TBL] [Abstract][Full Text] [Related]
33. Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats.
Bhutta HY; Rajpal N; White W; Freudenberg JM; Liu Y; Way J; Rajpal D; Cooper DC; Young A; Tavakkoli A; Chen L
PLoS One; 2015; 10(3):e0122273. PubMed ID: 25798945
[TBL] [Abstract][Full Text] [Related]
34. GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: a comparison with intensive lifestyle modification.
Vetter ML; Wadden TA; Teff KL; Khan ZF; Carvajal R; Ritter S; Moore RH; Chittams JL; Iagnocco A; Murayama K; Korus G; Williams NN; Rickels MR
Diabetes; 2015 Feb; 64(2):434-46. PubMed ID: 25204975
[TBL] [Abstract][Full Text] [Related]
35. BCAA Supplementation in Mice with Diet-induced Obesity Alters the Metabolome Without Impairing Glucose Homeostasis.
Lee J; Vijayakumar A; White PJ; Xu Y; Ilkayeva O; Lynch CJ; Newgard CB; Kahn BB
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33765118
[TBL] [Abstract][Full Text] [Related]
36. Repletion of branched chain amino acids reverses mTORC1 signaling but not improved metabolism during dietary protein dilution.
Maida A; Chan JSK; Sjøberg KA; Zota A; Schmoll D; Kiens B; Herzig S; Rose AJ
Mol Metab; 2017 Aug; 6(8):873-881. PubMed ID: 28752051
[TBL] [Abstract][Full Text] [Related]
37. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
38. Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery.
Sterl K; Wang S; Oestricker L; Wallendorf MJ; Patterson BW; Reeds DN; Wice BM
Peptides; 2016 Aug; 82():76-84. PubMed ID: 27288245
[TBL] [Abstract][Full Text] [Related]
39. Roux-en-Y Gastric Bypass Improves Hepatic Glucose Metabolism Involving Down-Regulation of Protein Tyrosine Phosphatase 1B in Obese Rats.
Mu S; Liu J; Guo W; Zhang S; Xiao X; Wang Z; Zhang J
Obes Facts; 2017; 10(3):191-206. PubMed ID: 28564652
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Diabetes Remission and Micronutrient Deficiency in a Mildly Obese Diabetic Rat Model Undergoing SADI-S Versus RYGB.
Wang T; Shen Y; Qiao Z; Wang Y; Zhang P; Yu B
Obes Surg; 2019 Apr; 29(4):1174-1184. PubMed ID: 30610678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
